Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Korea Vaccine Sales is a South Korean pharmaceutical and medical device company that serves as the primary commercialization and distribution arm for the Korea Vaccine Group. The company specializes in the supply of essential biological products, including BCG vaccines for tuberculosis and various seasonal influenza vaccines. Notably, Korea Vaccine Sales gained international recognition for its role in distributing "K-Syringes," which are low dead space (LDS) syringes designed to maximize vaccine doses during the COVID-19 pandemic. The company manages a robust logistics network to support the South Korean national immunization program and partners with global pharmaceutical firms to import and distribute specialized vaccines. In addition to vaccines, the company provides a range of medical consumables and devices to hospitals and clinics nationwide. Through its strategic sales operations, Korea Vaccine Sales ensures the availability of critical preventative healthcare solutions across the Korean market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Korea Vaccine Sales.